Developer docs
API playgroundTry for free, no card

Search company profiles

Montefiore Einstein Comprehensive Cancer Center

Full company profile

uuid0042tr1

Namestring
Montefiore Einstein Comprehensive Cancer Center
Legal namestring
Montefiore Einstein Comprehensive Cancer Center
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Montefiore Einstein Comprehensive Cancer Center is a non-profit NCI-designated comprehensive cancer center founded in 1972 and based in the Bronx, New York. It is one of only 56 such centers in the United States and the only NCI-designated comprehensive cancer center located between Westchester and Buffalo. The center is part of the Montefiore Einstein Health System and operates as the clinical arm of Albert Einstein College of Medicine's cancer research enterprise, integrating academic research with patient care to translate scientific discoveries into clinical treatments.

The center provides comprehensive cancer treatment across more than 400 cancer types through 14 multidisciplinary disease-focused teams. Core services include surgery, chemotherapy, immunotherapy, radiation therapy, hormone therapy, precision medicine, bone marrow transplant, and cellular therapy. It maintains 500+ active clinical research studies with 1965 patients enrolled in cancer clinical trials and draws $69M in cancer-related research funding. Supporting infrastructure includes state-of-the-art molecular imaging (BLI, FMI, PET, SPECT), image-guided therapies, a Cancer Navigator Program, and extensive support services covering mental health, nutrition, rehabilitation, survivorship, and financial counseling. The center also operates community outreach programs (BRONx-CAN, BOLD) and screening programs across seven cancer types.

Revenue is generated primarily through patient care services — insurance reimbursements, Medicare/Medicaid, and patient payments — for the clinical services described above. The center employs 700+ healthcare professionals (physicians, nurse practitioners, physician assistants, allied health) and serves 200,000+ outpatient visits annually. Its go-to-market motion is community-led, reaching patients through community outreach, screenings, educational events, and a hybrid of self-referrals and physician referrals, with consultations available in-person, by phone, or video. The center has maintained NCI accreditation for over 50 consecutive years and is ranked in the top 1% of U.S. hospitals for cancer care by U.S. News & World Report (2025).

Short descriptiontext

Montefiore Einstein Comprehensive Cancer Center is an NCI-designated comprehensive cancer center in the Bronx providing multidisciplinary treatment for 400+ cancer types through 14 disease-focused teams, integrated with Albert Einstein College of Medicine research and serving the New York metropolitan area.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBronx, United States
HQ citystring
Bronx
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer care services, oncology treatment, clinical research trials, cancer screening programs, patient navigation services
Industry5 codes
1Oncology & Cancer Specialty Hospitals
CodeHLAFAHACPrimaryYes
2Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
CodeHLAFABAIPrimaryNo
3Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring)
CodeHLAAABAJPrimaryNo
4Nuclear Medicine Clinical Services & Therapy Centers
CodeHLAIAGAIPrimaryNo
5Breast Imaging Centers (Mammography/Tomosynthesis)
CodeHLAFAKADPrimaryNo
NAICS code3 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
  • General Medical and Surgical Hospitals622110
  • Medical and Diagnostic Laboratories6215
SIC code3 codes
  • Services-General Medical & Surgical Hospitals, Nec8062
  • Services-Health Services8000
  • Services-Medical Laboratories8071
Product category
Oncology / Cancer Care Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Patient Care Services
TypeProfessional Services
Description

Healthcare services revenue from cancer treatment including chemotherapy, immunotherapy, radiation therapy, surgery, bone marrow transplant and cellular therapy. Revenue generated through insurance reimbursements, Medicare/Medicaid, and patient payments.

montefioreeinstein.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Montefiore Einstein Comprehensive Cancer Center is an NCI-designated comprehensive cancer center providing multidisciplinary cancer diagnosis, treatment, and care across more than 400 cancer types. It delivers chemotherapy, immunotherapy, radiation therapy, surgery, precision medicine, bone marrow transplant and cellular therapy, supported by 500+ active clinical trials and integrated with Albert Einstein College of Medicine research. The center also offers patient navigation, support services, community screenings, and outreach programs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 200,000+ outpatient visits annually
+4 more records
Product overview1 text field

Montefiore Einstein Comprehensive Cancer Center is a unified NCI-designated comprehensive cancer center offering a comprehensive portfolio of cancer care services. The center provides treatment across over 400 cancer types through multidisciplinary teams, integrating clinical care with academic research. Core offerings include surgical, chemotherapy, immunotherapy, radiation therapy, precision medicine, bone marrow transplant and cellular therapy programs, complemented by over 500 active clinical trials. The center also provides extensive patient support services (navigator program, mental health, nutrition, rehabilitation, survivorship), community outreach (BRONx-CAN, BOLD), cancer screenings, and research programs (tumor microenvironment, stem cell biology, therapeutics, epidemiology). Education and training programs support professional development across all career stages.

Product and service1 record
1Cancer Treatment Services
CategoryOncology Treatment Services
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Integrated academic partnership providing research infrastructure, physician-scientist workforce, and educational programs. The cancer center serves as the clinical arm of Einstein's cancer research enterprise, enabling direct translation of scientific discoveries into patient care.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

NCI-designated comprehensive cancer center providing multidisciplinary oncology care, clinical trials, and research. Comparable peer in NCI designation, academic affiliation, and comprehensive cancer service model.

TypeBroad incumbent
Description

NCI-designated comprehensive cancer center affiliated with Harvard, providing oncology care, clinical trials, and research. Comparable peer for academic cancer center model and clinical research intensity.

TypeDirect peer
Description

NCI-designated comprehensive cancer center affiliated with Columbia University, offering oncology treatment, clinical trials, and research programs. Competes with Montefiore Einstein for academic affiliations and patient referrals in NYC.

TypeBroad incumbent
Description

NCI-designated comprehensive cancer center in Tampa, FL, with a large clinical and research enterprise. Comparable peer in scale, NCI designation, and integration of clinical care with translational research.

TypeDirect peer
Description

NCI-designated comprehensive cancer center in New York City offering the full spectrum of oncology care, clinical trials, and research. Most direct geographic competitor in the New York metro for high-acuity cancer cases.

TypeDirect peer
Description

NCI-designated comprehensive cancer center in Buffalo, NY, providing multidisciplinary oncology care, research, and education. Comparable peer in terms of NCI designation, academic affiliation, and comprehensive cancer service model.

TypeBroad incumbent
Description

NCI-designated comprehensive cancer center with a national footprint focused on oncology research, treatment, and precision medicine. Comparable peer for clinical trial volume and translational research integration.

TypeDirect peer
Description

NCI-designated comprehensive cancer center in Atlanta, GA, providing multidisciplinary oncology care, clinical trials, and research. Comparable peer in NCI designation, academic integration, and comprehensive service model.

TypeBroad incumbent
Description

NCI-designated cancer center in Philadelphia providing oncology treatment, research, and clinical trials. Comparable peer for academic cancer center model with strong clinical trial portfolio.

10Perlmutter Cancer Center (NYU Langone Health)
TypeDirect peer
Description

NCI-designated comprehensive cancer center at NYU Langone providing multidisciplinary oncology care, clinical trials, and translational research. Direct peer competing for patients and research talent in the New York metro.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Montefiore Einstein Comprehensive Cancer Center

Oncology / Cancer Care Servicescancer.montefioreeinstein.org

Montefiore Einstein Comprehensive Cancer Center is an NCI-designated comprehensive cancer center in the Bronx providing multidisciplinary treatment for 400+ cancer types through 14 disease-focused teams, integrated with Albert Einstein College of Medicine research and serving the New York metropolitan area.

What Montefiore Einstein Comprehensive Cancer Center does

Montefiore Einstein Comprehensive Cancer Center is a non-profit NCI-designated comprehensive cancer center founded in 1972 and based in the Bronx, New York. It is one of only 56 such centers in the United States and the only NCI-designated comprehensive cancer center located between Westchester and Buffalo. The center is part of the Montefiore Einstein Health System and operates as the clinical arm of Albert Einstein College of Medicine's cancer research enterprise, integrating academic research with patient care to translate scientific discoveries into clinical treatments.

The center provides comprehensive cancer treatment across more than 400 cancer types through 14 multidisciplinary disease-focused teams. Core services include surgery, chemotherapy, immunotherapy, radiation therapy, hormone therapy, precision medicine, bone marrow transplant, and cellular therapy. It maintains 500+ active clinical research studies with 1965 patients enrolled in cancer clinical trials and draws $69M in cancer-related research funding. Supporting infrastructure includes state-of-the-art molecular imaging (BLI, FMI, PET, SPECT), image-guided therapies, a Cancer Navigator Program, and extensive support services covering mental health, nutrition, rehabilitation, survivorship, and financial counseling. The center also operates community outreach programs (BRONx-CAN, BOLD) and screening programs across seven cancer types.

Revenue is generated primarily through patient care services — insurance reimbursements, Medicare/Medicaid, and patient payments — for the clinical services described above. The center employs 700+ healthcare professionals (physicians, nurse practitioners, physician assistants, allied health) and serves 200,000+ outpatient visits annually. Its go-to-market motion is community-led, reaching patients through community outreach, screenings, educational events, and a hybrid of self-referrals and physician referrals, with consultations available in-person, by phone, or video. The center has maintained NCI accreditation for over 50 consecutive years and is ranked in the top 1% of U.S. hospitals for cancer care by U.S. News & World Report (2025).

Montefiore Einstein Comprehensive Cancer Center firmographics

Firmographics
Name
Montefiore Einstein Comprehensive Cancer Center
Legal name
Montefiore Einstein Comprehensive Cancer Center
Website
https://cancer.montefioreeinstein.org
Company type
Private
Operating status
Operating
Headcount range
101–250 employees
Short description
Montefiore Einstein Comprehensive Cancer Center is an NCI-designated comprehensive cancer center in the Bronx providing multidisciplinary treatment for 400+ cancer types through 14 disease-focused teams, integrated with Albert Einstein College of Medicine research and serving the New York metropolitan area.
Ownership category
akta.pro rank

Montefiore Einstein Comprehensive Cancer Center industry classification

Industry
Product category
Oncology / Cancer Care Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), General Medical and Surgical Hospitals (622110), Medical and Diagnostic Laboratories (6215)
SIC
Services-General Medical & Surgical Hospitals, Nec (8062), Services-Health Services (8000), Services-Medical Laboratories (8071)
akta.pro primary industry
Oncology & Cancer Specialty Hospitals (HLAFAHAC)
akta.pro secondary industries
Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI), Breast Imaging Centers (Mammography/Tomosynthesis) (HLAFAKAD)

Keywords

  • Cancer care services
  • Oncology treatment
  • Clinical research trials
  • Cancer screening programs
  • Patient navigation services

Where Montefiore Einstein Comprehensive Cancer Center is headquartered

Location

Headquarters

HQ city
Bronx
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Montefiore Einstein Comprehensive Cancer Center business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Patient Care Services: Healthcare services revenue from cancer treatment including chemotherapy, immunotherapy, radiation therapy, surgery, bone marrow transplant and cellular therapy. Revenue generated through insurance reimbursements, Medicare/Medicaid, and patient payments.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Montefiore Einstein Comprehensive Cancer Center product offering

Product offering

Core offering

Montefiore Einstein Comprehensive Cancer Center is an NCI-designated comprehensive cancer center providing multidisciplinary cancer diagnosis, treatment, and care across more than 400 cancer types. It delivers chemotherapy, immunotherapy, radiation therapy, surgery, precision medicine, bone marrow transplant and cellular therapy, supported by 500+ active clinical trials and integrated with Albert Einstein College of Medicine research. The center also offers patient navigation, support services, community screenings, and outreach programs.

Product overview

Montefiore Einstein Comprehensive Cancer Center is a unified NCI-designated comprehensive cancer center offering a comprehensive portfolio of cancer care services. The center provides treatment across over 400 cancer types through multidisciplinary teams, integrating clinical care with academic research. Core offerings include surgical, chemotherapy, immunotherapy, radiation therapy, precision medicine, bone marrow transplant and cellular therapy programs, complemented by over 500 active clinical trials. The center also provides extensive patient support services (navigator program, mental health, nutrition, rehabilitation, survivorship), community outreach (BRONx-CAN, BOLD), cancer screenings, and research programs (tumor microenvironment, stem cell biology, therapeutics, epidemiology). Education and training programs support professional development across all career stages.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cancer Treatment Services

Quantifiable outcome

  • 200,000+ outpatient visits annually
  • +4 more outcomes

Companies that use Montefiore Einstein Comprehensive Cancer Center

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Montefiore Einstein Comprehensive Cancer Center technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Montefiore Einstein Comprehensive Cancer Center partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Albert Einstein College of MedicinecoreStrategic or Co-development PartnerIntegrated academic partnership providing research infrastructure, physician-scientist workforce, and educational programs. The cancer center serves as the clinical arm of Einstein's cancer research enterprise, enabling direct translation of scientific discoveries into patient care.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Montefiore Einstein Comprehensive Cancer Center competitors and assessment

Company assessment

Direct peers

  • Sylvester Comprehensive Cancer Center (University of Miami): NCI-designated comprehensive cancer center providing multidisciplinary oncology care, clinical trials, and research. Comparable peer in NCI designation, academic affiliation, and comprehensive cancer service model.
  • Herbert Irving Comprehensive Cancer Center (Columbia University): NCI-designated comprehensive cancer center affiliated with Columbia University, offering oncology treatment, clinical trials, and research programs. Competes with Montefiore Einstein for academic affiliations and patient referrals in NYC.
  • Memorial Sloan Kettering Cancer Center: NCI-designated comprehensive cancer center in New York City offering the full spectrum of oncology care, clinical trials, and research. Most direct geographic competitor in the New York metro for high-acuity cancer cases.
  • Roswell Park Comprehensive Cancer Center: NCI-designated comprehensive cancer center in Buffalo, NY, providing multidisciplinary oncology care, research, and education. Comparable peer in terms of NCI designation, academic affiliation, and comprehensive cancer service model.
  • Winship Cancer Institute of Emory University: NCI-designated comprehensive cancer center in Atlanta, GA, providing multidisciplinary oncology care, clinical trials, and research. Comparable peer in NCI designation, academic integration, and comprehensive service model.
  • Perlmutter Cancer Center (NYU Langone Health): NCI-designated comprehensive cancer center at NYU Langone providing multidisciplinary oncology care, clinical trials, and translational research. Direct peer competing for patients and research talent in the New York metro.

Broad incumbents

  • Dana-Farber Cancer Institute: NCI-designated comprehensive cancer center affiliated with Harvard, providing oncology care, clinical trials, and research. Comparable peer for academic cancer center model and clinical research intensity.
  • Moffitt Cancer Center: NCI-designated comprehensive cancer center in Tampa, FL, with a large clinical and research enterprise. Comparable peer in scale, NCI designation, and integration of clinical care with translational research.
  • City of Hope Comprehensive Cancer Center: NCI-designated comprehensive cancer center with a national footprint focused on oncology research, treatment, and precision medicine. Comparable peer for clinical trial volume and translational research integration.
  • Fox Chase Cancer Center: NCI-designated cancer center in Philadelphia providing oncology treatment, research, and clinical trials. Comparable peer for academic cancer center model with strong clinical trial portfolio.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Montefiore Einstein Comprehensive Cancer Center social profiles

Digital presence

Montefiore Einstein Comprehensive Cancer Center compliance and trust

Trust signal

Compliance6 records

Montefiore Einstein Comprehensive Cancer Center financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Montefiore Einstein Comprehensive Cancer Center leadership team

Management profile

Number of profiles

Montefiore Einstein Comprehensive Cancer Center funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Montefiore Einstein Comprehensive Cancer Center M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Montefiore Einstein Comprehensive Cancer Center

What does Montefiore Einstein Comprehensive Cancer Center do?

Montefiore Einstein Comprehensive Cancer Center is an NCI-designated comprehensive cancer center providing multidisciplinary cancer diagnosis, treatment, and care across more than 400 cancer types. It delivers chemotherapy, immunotherapy, radiation therapy, surgery, precision medicine, bone marrow transplant and cellular therapy, supported by 500+ active clinical trials and integrated with Albert Einstein College of Medicine research. The center also offers patient navigation, support services, community screenings, and outreach programs.

Is Montefiore Einstein Comprehensive Cancer Center a public or private company?

Montefiore Einstein Comprehensive Cancer Center is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Montefiore Einstein Comprehensive Cancer Center founded?

Montefiore Einstein Comprehensive Cancer Center was founded in -1. It employs 101 to 250 people.

Where is Montefiore Einstein Comprehensive Cancer Center based?

Montefiore Einstein Comprehensive Cancer Center is headquartered in Bronx, United States, in the North America region.

How does Montefiore Einstein Comprehensive Cancer Center make money?

One revenue line is on record: patient Care Services.

Who are Montefiore Einstein Comprehensive Cancer Center's main competitors?

Direct peers on record are Sylvester Comprehensive Cancer Center (University of Miami), Herbert Irving Comprehensive Cancer Center (Columbia University), Memorial Sloan Kettering Cancer Center, Roswell Park Comprehensive Cancer Center, Winship Cancer Institute of Emory University and Perlmutter Cancer Center (NYU Langone Health). Broad incumbents are Dana-Farber Cancer Institute, Moffitt Cancer Center, City of Hope Comprehensive Cancer Center and Fox Chase Cancer Center.

Does Montefiore Einstein Comprehensive Cancer Center have an API?

No public API is recorded for Montefiore Einstein Comprehensive Cancer Center.

What industry is Montefiore Einstein Comprehensive Cancer Center in?

Montefiore Einstein Comprehensive Cancer Center's product category is Oncology / Cancer Care Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 622310 and its SIC code is 8062.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireLos diagnósticos de cáncer de pulmón en estadio avanzado caen a un mínimo histórico en el BronxMontefiore Einstein Comprehensive Cancer Center announced that for the first time in decades, more Bronx residents are being diagnosed with stage I lung cancer rather than stage IV, reversing a long-standing trend of late-stage diagnoses in the community. The center attributed this shift to improved low-dose CT screening, the FAST clinic using AI to track incidental pulmonary nodules, and expanded community education, resulting in over 80 lung cancer diagnoses since the clinic opened in 2021. The International Association for the Study of Lung Cancer recognized MECCC's lung cancer team as the only award recipient in North America in September.PR NewswireLate-Stage Lung Cancer Diagnoses Plummet to a New Low in the BronxMontefiore Einstein Comprehensive Cancer Center announced that for the first time in decades, more people in the Bronx are being diagnosed with stage I versus stage IV lung cancer, marking a significant 'stage shift' driven by enhanced screening programs including a FAST Clinic, clinical trial enrollment, and community education. Approximately 20% of screen-detected lung cancer patients are being enrolled in clinical trials, and the center was recognized by the International Association for the Study of Lung Cancer as the only award recipient in North America for outstanding cancer care.PR NewswireGlioblastomas Affect Much More Than Just the BrainScientists at Montefiore Einstein Comprehensive Cancer Center and Albert Einstein College of Medicine have discovered that glioblastoma—the deadliest form of brain cancer—not only affects the brain but also erodes skull bone and alters the skull marrow's immune landscape, shifting it toward pro-inflammatory immune cells. The researchers found that anti-osteoporosis drugs halted skull erosion but one drug (zoledronic acid) fueled tumor progression in a type of glioblastoma, while both drugs blocked the beneficial effects of anti-PD-L1 immunotherapy. The findings suggest glioblastoma should be treated as a systemic rather than purely local disease, potentially explaining why current therapies have failed and opening pathways for new treatment strategies targeting the immune system.PR NewswireEl equipo de Cáncer de Pulmón de Montefiore Einstein Comprehensive Cancer Center obtiene reconocimiento internacional por su atención médica excepcionalMontefiore Einstein Comprehensive Cancer Center's lung cancer team was recognized by the International Association for the Study of Lung Cancer with the Cancer Care Team Award at the organization's annual meeting in Barcelona, Spain, becoming the only North American institution to receive the honor this year. The award, nominated by lung cancer survivor Jeanna Dickerson, highlights the center's multidisciplinary approach to patient care and compassionate treatment tailored to individual patient goals and lifestyles. The recognition underscores MECCC's standing as a National Cancer Institute-designated comprehensive cancer center serving the Bronx area of New York City since 1971.PR NewswireMontefiore Einstein Comprehensive Cancer Center's Lung Cancer Team Earns International Recognition for Exceptional CareMontefiore Einstein Comprehensive Cancer Center's lung cancer team received the International Association for the Study of Lung Cancer's North American Cancer Care Team Award during the IASLC annual meeting in Barcelona, Spain. MECCC was the only center in North America honored with this award this year, selected from institutions across international geographic regions. The team was nominated by lung cancer survivor Jeanna Dickerson, who credited the team with supporting her through treatment that included neoadjuvant immunotherapy before surgery.PR NewswireRespiratory Viruses Can Wake Up Breast Cancer Cells in LungsResearchers at the University of Colorado Anschutz Medical Campus, Montefiore Einstein Comprehensive Cancer Center, and Utrecht University have discovered that respiratory infections like COVID-19 and influenza can reactivate dormant breast cancer cells in the lungs, potentially leading to new metastatic tumors. This study indicates that cancer survivors infected with these viruses may face heightened risks of metastasis and mortality, underscoring the need for precautionary measures. Further research aims to develop interventions to minimize the risk of cancer progression following respiratory infections.PR NewswireMontefiore Einstein Comprehensive Cancer Center Upholds Top Honor for Cancer CareMontefiore Einstein Comprehensive Cancer Center has received a Three-Year Accreditation from the Commission on Cancer of the American College of Surgeons, continuing its status as one of the nation's top cancer centers. The CoC surveyor rated the center as "exceptional," specifically commending its commitment to research, surgical excellence, and nursing continuing education. The accreditation recognizes the center's performance across 38 quality care standards, including its management of 320+ active clinical trials and initiatives such as an AI-powered lung cancer screening program that contributed to a 12% reduction in advanced stage 4 lung cancers in the Bronx.PR NewswireMontefiore Einstein Comprehensive Cancer Center (MECCC) recibe la más alta distinción por su labor en la atención médica del cáncerMontefiore Einstein Comprehensive Cancer Center (MECCC) has been re-accredited for three years by the Commission on Cancer (CoC) of the American College of Surgeons, based on its comprehensive cancer center status granted by the National Cancer Institute in 2023. The CoC inspector rated the center as "exceptional," awarding it the highest score for its commitment to research, surgical excellence, and continuous nursing staff training. The accreditation recognises the MECCC's ranking within the top one percent of U.S. hospitals for cancer care, its enrollment of over 1,000 patients in more than 320 active clinical trials, and initiatives such as an AI-driven lung cancer screening programme that contributed to a nearly 12 percent reduction in stage-4 lung cancer incidence in the Bronx.AscopubsAI Patient Navigator Re-engages Patients to Attend Colonoscopy Screening AppointmentsA quality improvement study at Montefiore Einstein Comprehensive Cancer Center utilized an AI patient navigator named MyEleanor to re-engage patients who missed initial colonoscopy appointments. The implementation increased the completion rate from 10% to 19% and boosted total patient volume by 36%, demonstrating the technology's effectiveness in reaching underserved populations. Researchers highlighted the potential for such tools to alleviate staff burdens while addressing barriers to cancer screening.PR NewswireMontefiore Einstein Comprehensive Cancer Center Awarded Comprehensive Designation from the National Cancer InstituteThe Montefiore Einstein Comprehensive Cancer Center (MECCC) has been awarded the comprehensive designation by the National Cancer Institute (NCI), recognizing its contributions to cancer science and clinical care. As part of this recognition, MECCC received a five-year, $20 million Cancer Center Support Grant to advance novel research and improve equitable access to care in the Bronx and surrounding areas.